Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging

Chidambaram Gunanathan; Adi Pais; Edna Furman-Haran; Dalia Seger; Erez Eyal; Sarbani Mukhopadhyay; Yehoshoa Ben-David; Gregory Leitus; Hagai Cohen; Ayelet Vilan; Hadassa Degani; David Milstein

doi:10.1021/bc700230m

Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging

Chidambaram Gunanathan, Adi Pais, Edna Furman-Haran, Dalia Seger, Erez Eyal, Sarbani Mukhopadhyay, Yehoshoa Ben-David, Gregory Leitus, Hagai Cohen, Ayelet Vilan, Hadassa Degani, David Milstein

Weizmann Institute of Science, Israel

Research output: Contribution to journal › Article

25 Citations (Scopus)

Abstract

Novel estrogen-conjugated pyridine-containing Gd(III) and Eu(III) contrast agents (EPTA-Gd/Eu) were designed and effectively synthesized. Convenient to administration and MRI experiments, both EPTA-Gd and EPTA-Eu are soluble in water. The EPTA-Gd selectively binds with a micromolar affinity to the estrogen receptor and induces proliferation of human breast cancer cells. The EPTA-Gd is not lethal and does not cause any adverse effects when administrated intravenously. It enhances T₁ and T₂ nuclear relaxation rates of water and serves as a selective contrast agent for localizing the estrogen receptor by MRI.

Original language	English
Pages (from-to)	1361-1365
Number of pages	5
Journal	Bioconjugate Chemistry
Volume	18
Issue number	5
DOIs	https://doi.org/10.1021/bc700230m
Publication status	Published - Sep 1 2007

ASJC Scopus subject areas

Biotechnology
Bioengineering
Biomedical Engineering
Pharmacology
Pharmaceutical Science
Organic Chemistry

Access to Document

10.1021/bc700230m

Fingerprint Dive into the research topics of 'Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging'. Together they form a unique fingerprint.

Cite this

Gunanathan, C., Pais, A., Furman-Haran, E., Seger, D., Eyal, E., Mukhopadhyay, S., Ben-David, Y., Leitus, G., Cohen, H., Vilan, A., Degani, H., & Milstein, D. (2007). Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging. Bioconjugate Chemistry, 18(5), 1361-1365. https://doi.org/10.1021/bc700230m

Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging. / Gunanathan, Chidambaram; Pais, Adi; Furman-Haran, Edna; Seger, Dalia; Eyal, Erez; Mukhopadhyay, Sarbani; Ben-David, Yehoshoa; Leitus, Gregory; Cohen, Hagai; Vilan, Ayelet; Degani, Hadassa; Milstein, David.

In: Bioconjugate Chemistry, Vol. 18, No. 5, 01.09.2007, p. 1361-1365.

Research output: Contribution to journal › Article

Gunanathan, Chidambaram ; Pais, Adi ; Furman-Haran, Edna ; Seger, Dalia ; Eyal, Erez ; Mukhopadhyay, Sarbani ; Ben-David, Yehoshoa ; Leitus, Gregory ; Cohen, Hagai ; Vilan, Ayelet ; Degani, Hadassa ; Milstein, David. / Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging. In: Bioconjugate Chemistry. 2007 ; Vol. 18, No. 5. pp. 1361-1365.

@article{d26c592dc34649da967341fb41ad3337,

title = "Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging",

abstract = "Novel estrogen-conjugated pyridine-containing Gd(III) and Eu(III) contrast agents (EPTA-Gd/Eu) were designed and effectively synthesized. Convenient to administration and MRI experiments, both EPTA-Gd and EPTA-Eu are soluble in water. The EPTA-Gd selectively binds with a micromolar affinity to the estrogen receptor and induces proliferation of human breast cancer cells. The EPTA-Gd is not lethal and does not cause any adverse effects when administrated intravenously. It enhances T1 and T2 nuclear relaxation rates of water and serves as a selective contrast agent for localizing the estrogen receptor by MRI.",

author = "Chidambaram Gunanathan and Adi Pais and Edna Furman-Haran and Dalia Seger and Erez Eyal and Sarbani Mukhopadhyay and Yehoshoa Ben-David and Gregory Leitus and Hagai Cohen and Ayelet Vilan and Hadassa Degani and David Milstein",

year = "2007",

month = sep,

day = "1",

doi = "10.1021/bc700230m",

language = "English",

volume = "18",

pages = "1361--1365",

journal = "Bioconjugate Chemistry",

issn = "1043-1802",

publisher = "American Chemical Society",

number = "5",

}

TY - JOUR

T1 - Water-soluble contrast agents targeted at the estrogen receptor for molecular magnetic resonance imaging

AU - Gunanathan, Chidambaram

AU - Pais, Adi

AU - Furman-Haran, Edna

AU - Seger, Dalia

AU - Eyal, Erez

AU - Mukhopadhyay, Sarbani

AU - Ben-David, Yehoshoa

AU - Leitus, Gregory

AU - Cohen, Hagai

AU - Vilan, Ayelet

AU - Degani, Hadassa

AU - Milstein, David

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Novel estrogen-conjugated pyridine-containing Gd(III) and Eu(III) contrast agents (EPTA-Gd/Eu) were designed and effectively synthesized. Convenient to administration and MRI experiments, both EPTA-Gd and EPTA-Eu are soluble in water. The EPTA-Gd selectively binds with a micromolar affinity to the estrogen receptor and induces proliferation of human breast cancer cells. The EPTA-Gd is not lethal and does not cause any adverse effects when administrated intravenously. It enhances T1 and T2 nuclear relaxation rates of water and serves as a selective contrast agent for localizing the estrogen receptor by MRI.

AB - Novel estrogen-conjugated pyridine-containing Gd(III) and Eu(III) contrast agents (EPTA-Gd/Eu) were designed and effectively synthesized. Convenient to administration and MRI experiments, both EPTA-Gd and EPTA-Eu are soluble in water. The EPTA-Gd selectively binds with a micromolar affinity to the estrogen receptor and induces proliferation of human breast cancer cells. The EPTA-Gd is not lethal and does not cause any adverse effects when administrated intravenously. It enhances T1 and T2 nuclear relaxation rates of water and serves as a selective contrast agent for localizing the estrogen receptor by MRI.

UR - http://www.scopus.com/inward/record.url?scp=34648840361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34648840361&partnerID=8YFLogxK

U2 - 10.1021/bc700230m

DO - 10.1021/bc700230m

M3 - Article

C2 - 17784729

AN - SCOPUS:34648840361

VL - 18

SP - 1361

EP - 1365

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 5

ER -